Lawson Health Research Institute
Canadian study concludes plasma exchange is not beneficial in multiple myeloma treatment
Published in Health Risk Factor Week, January 3rd, 2006
More and more, plasma exchange is being endorsed by a number of health-related associations as useful for preventing acute renal failure at the onset of multiple myeloma. However, a recent study at 14 medical centers across Canada found no conclusive evidence to suggest that this treatment provides any kind of benefit to patients.
"In what we believe to be the largest randomized, controlled trial conducted to date, we found no conclusive evidence that plasma exchange provides a substantial benefit in reducing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- BearingPoint, Inc.
U.S. CDC awards BearingPoint $9.8M contract to support center for Public Health Informatics - Cantel Medical Corp.
Infection prevention device maker reports EPS of $0.23 - Centre Hospitalier de l'Universite de Amiens
Prevention practices and cancer screening among general practitioners analyzed - Accentia Biopharmaceuticals, Inc.
Automated cell culture instrument introduced to biotech industry - Advanced Medical Optics, Inc.
Ophthalmology firm announces effectiveness of registration statement for notes due in 2025 - Advocate Health Care
Advocate Health Care to use speech recognition technology - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
